Monitor for upcoming earnings or clinical trial updates; coordinated selling by multiple C-suite executives may signal lack of near-term confidence despite recent price strength. Consider hedging if positioned long.
Price Chart
Executive Summary
Seven open-market share sales by four insiders at Stoke Therapeutics over the past week, including the CFO, Chief Medical Officer, General Counsel, and Chief Patient Officer, totaled approximately $772,200 in proceeds. The transactions include both routine sales and derivative exercises, with the majority of economic activity representing open-market selling.
Key Financial Metrics
Key Facts
- CFO (Leggett Thomas) sold $67,980 worth of shares in open-market transaction
- Chief Medical Officer (Ticho Barry) sold $234,647 in shares and exercised derivatives for 2,730 shares (non-cash value of $2,989)
- General Counsel (Allan Jonathan) sold $424,439 in shares across two days
- Total open-market sales by insiders: $772,207
- All sales occurred between $29.99 and $33.64 per share
- No open-market purchases reported in the cluster
Financial Impact
$772,207 in net insider selling over 7 days
Risk Factors
- Perception of insider pessimism due to absence of offsetting buys
- Potential for further selling if near-term catalysts disappoint
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (8 trades, 7d window) | cluster-STOK-1774383582951 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 19, 2026 6w ago | Insider Cluster | $33.03 $28.93 | ▼ −12.41% | ▼ −10.46% | $25.91 (−21.56%) |
Aug 3, 2026 8w ago | 8-K | $31.67 $30.89 | ▲ +2.46% | ▲ +1.22% | $25.91 (+18.19%) |
Aug 3, 2026 8w ago | 424B5 | $31.67 $30.89 | ▲ +2.46% | ▲ +1.22% | $25.91 (+18.19%) |
Jun 30, 2026 13w ago | 8-K | $32.72 $29.31 | ▼ −10.42% | ▼ −9.39% | $25.91 (−20.82%) |
May 7, 2026 21w ago | 8-K | $32.89 $30.01 | ▼ −8.76% | ▼ −8.78% | $25.91 (−21.23%) |
Apr 22, 2026 23w ago | DEFA14A | $34.93 $30.30 | ▼ −13.27% | ▼ −17.90% | $25.91 (−25.83%) |
Apr 7, 2026 25w ago | 8-K | $34.87 $32.96 | ▼ −5.48% | ▼ −14.02% | $25.91 (−25.70%) |
Mar 13, 2026 29w ago | Insider Cluster | $33.19 $35.05 | ▼ −5.60% | ▼ −2.02% | $25.91 (+21.94%) |
Mar 10, 2026 29w ago | Insider Cluster | $38.35 $34.87 | ▼ −9.07% | ▼ −8.92% | $25.91 (−32.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access